A fatty liver disease known as NASH — non-alcoholic steatohepatitis — is the nation’s major cause of chronic liver disease, and is projected to become the most common indicator for…
Asthma, Alzheimer’s, cancer, the aging immune system, diabetes, precision medicine and Valley fever are among the health issues affecting Arizonans and the nation that are being tackled by University of…
AMAG Pharmaceuticals, Inc. announced it has entered into a definitive agreement to divest Cord Blood Registry to GI Partners, a private equity investment firm, for $530 million in an all…
A physician-scientist at the University of Arizona Cancer Center investigated a novel treatment for pancreatic cancer patients whose tumors exhibited a harmful genetic mutation. The results, in which a type…
Often what kills cancer patients is not the cancer at its original or primary site, but its spread to secondary sites within the body, through a process called metastasis. In…
Phoenix-based Axolotl Biologix announced a strategic partnership with Leonhardt Ventures to explore therapeutic and commercial opportunities of combining Leonhardt’s bioelectric + micro pump + mixed stem cell-based composition for organ regeneration with Axolotl Biologix’s amniotic-derived fluid…
Trying to build on Arizona’s significant investments in the life science discovery and healthcare delivery infrastructure, the state’s leaders are focused on bridging the funding gap that slows the growth…
This year alone, an estimated 13,000 Americans will be diagnosed with glioblastoma, which is the most deadly and aggressive form of brain cancer. In the ongoing pursuit of new therapies,…
Imagine how much patients could benefit if you could discover the presence of cancer, and even how that cancer develops over time, with a simple blood test. There is vast…
According to Morgan Stanley, the United States healthcare mergers and acquisitions market started 2018 with almost $39 billion worth of deals announced in January alone — the strongest start in more…
The University of Arizona Health Sciences and Banner Health have received a $9 million award from the National Institutes of Health for the All of Us Research Program. The program, which will…
Gene therapy could be the key to curing rare and life-threatening diseases, but high costs and potential negative effects are slowing the fledgling field, experts say. In gene therapy, normal…
